Please assess the completion status of the following clinical trial:

Trial Title: Ablation Confirmation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. A patient with at least one soft-tissue liver lesion less than or equal to 5cm undergoing microwave ablation using the NEUWAVE Microwave Ablation System. Note: a patient cannot have more than 3 lesions ablated during the procedure.~2. Intent to use Ablation Confirmation software (any AC software version permitted) during the ablation procedure.~3. Written Informed Consent to voluntarily participate in the study, follow CT scan schedule, and authorize the transfer of his/her data to the Sponsor~4. Patients greater than or equal to 22 years of age~5. Performance status 0-2 (Eastern Cooperative Oncology Group \[ECOG\]) classification~6. Class A or B functional hepatic reserve based on the Child-Pugh score.~7. Lesion must be visualized by non-contrast enhanced CT scan or the patient must tolerate contrast and meet institutional guidelines for contrast use based on glomerular filtration rate (GFR).~Exclusion Criteria:~1. Active bacterial infection or fungal infection on the day of the ablation.~2. Patients with implantable pacemakers or other electronic implants.~3. Platelet count less than 50,000/mm cubed.~4. Patients with uncorrectable coagulopathy at the time of ablation.~5. Currently breastfeeding or pregnant (latter confirmed by serum pregnancy test, per site's SOC).~6. Physical or psychological condition which would impair study participation.~7. ASA (American Society of Anesthesiologists) score of great or equal to 4.~8. Use of hydrodissection.~9. Systemic chemotherapy or radiation therapy for the liver, within 30 days prior to the study ablation procedure.~10. INR greater than 1.8.~11. Patient has participated in an investigational clinical study within 30 days of the screening visit for this study.~12. Patient judged unsuitable for study participation by the performing physician for any other reason.

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Microwave Ablation (Type: EXPERIMENTAL): NEUWAVE Microwave Ablation System with AC software for patients undergoing a percutaneous ablation of a soft tissue liver lesion by an interventional radiologist.

Based on this trial design, predict the completion outcome and termination type (if applicable).